WANBURY
Back to Cashflow Statement
|
WANBURY Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹0.66 Cr | ₹1.94 Cr | ₹-21 Cr | ₹13 Cr | ₹7.34 Cr |
What is the latest Net Cash Inflow / Outflow ratio of WANBURY ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2025 | ₹0.66 Cr |
| Mar2024 | ₹1.94 Cr |
| Mar2023 | ₹-21 Cr |
| Mar2022 | ₹13 Cr |
| Mar2021 | ₹7.34 Cr |
How is Net Cash Inflow / Outflow of WANBURY Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2025 | ₹0.66 Cr | -66.07 | |
| Mar2024 | ₹1.94 Cr | Positive | |
| Mar2023 | ₹-21 Cr | Negative | |
| Mar2022 | ₹13 Cr | 70.64 | |
| Mar2021 | ₹7.34 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of WANBURY
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| WANBURY | ₹1,201.4 Cr | 21% | 28.9% | 25.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹468,458.0 Cr | 0.7% | 8.1% | 16% | Stock Analytics | |
| DIVIS LABORATORIES | ₹193,383.0 Cr | 7% | 10.2% | 3.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹169,829.0 Cr | 2.5% | 11.3% | 49.6% | Stock Analytics | |
| CIPLA | ₹116,164.0 Cr | -0.3% | 4.1% | -3.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,648.0 Cr | -3.2% | -3.9% | -3% | Stock Analytics | |
WANBURY Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| WANBURY | 21% |
28.9% |
25.5% |
| SENSEX | 0.9% |
2.2% |
-7.5% |
You may also like the below Video Courses